Over The Counter Drugs Market Research Report by Product (Analgesics, Cough, Cold, & Flu Products, and Dermatology Products), Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Over The Counter Drugs Market Research Report by Product (Analgesics, Cough, Cold, & Flu Products, and Dermatology Products), Distribution Channel, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
221 Pages
January 2023
Region: Global
360iResearch™
ID: 4807786

UP TO €855EUR$895USD£752GBP OFF until Mar 31^st 2023

The Global Over The Counter Drugs Market size was estimated at USD 426.96 billion in 2022, USD 464.14 billion in 2023, and is projected to grow at a CAGR of 8.84% to reach USD 841.20 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Over The Counter Drugs Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Over The Counter Drugs Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Over The Counter Drugs Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Over The Counter Drugs Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Over The Counter Drugs Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market is studied across Analgesics, Cough, Cold, & Flu Products, Dermatology Products, Gastrointestinal Products, Ophthalmic Products, Sleeping Aids, Vitamins, Mineral, & Supplements, and Weight-Loss & Dietary Products.
Based on Distribution Channel, the market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Over The Counter Drugs Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Over The Counter Drugs Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Over The Counter Drugs Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Over The Counter Drugs Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Over The Counter Drugs Market, including Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, Cipla, Inc., Dr. Reddy's Laboratories, Glaxosmithkline PLC, Glenmark Pharmaceuticals Limited, Hetero Drugs Ltd., Johnson & Johnson Pvt. Ltd., Lupin Limited, Mankind Pharma, Mylan Pharmaceuticals Pvt. Ltd. by Viatris, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Over The Counter Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Over The Counter Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Over The Counter Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Over The Counter Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Over The Counter Drugs Market?
6. What is the market share of the leading vendors in the Global Over The Counter Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Over The Counter Drugs Market?

Frequently Asked Questions about the Global Over The Counter Drugs Market

What is the estimated value of the Global Over The Counter Drugs Market?

The Global Over The Counter Drugs Market was estimated to be valued at $426.96 Billion in 2022.

What is the growth rate of the Global Over The Counter Drugs Market?

The growth rate of the Global Over The Counter Drugs Market is 8.8%, with an estimated value of $841.2 Billion by 2030.

What is the forecasted size of the Global Over The Counter Drugs Market?

The Global Over The Counter Drugs Market is estimated to be worth $841.2 Billion by 2030.

Who are the key companies in the Global Over The Counter Drugs Market?

Key companies in the Global Over The Counter Drugs Market include Alembic Pharmaceuticals Ltd., Alkem Laboratories Limited, Cipla, Inc., Dr. Reddy's Laboratories, Glaxosmithkline PLC, Glenmark Pharmaceuticals Limited, Hetero Drugs Ltd., Johnson & Johnson Pvt. Ltd. and Mankind Pharma.

Report Attribute	Details
No. of Pages	221
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 426.96 Billion
Forecasted Market Value ( USD ) by 2030	$ 841.2 Billion
Compound Annual Growth Rate	8.8%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Cost effective way to treat minor health issues
5.1.1.2. Reduced burden of the physician
5.1.1.3. Favorable regulatory framework
5.1.2. Restraints
5.1.2.1. Presence of substitute drug due to saturating market
5.1.3. Opportunities
5.1.3.1. Increased accessibility through retail outlets and supermarkets
5.1.3.2. Technological advancement and product innovation
5.1.4. Challenges
5.1.4.1. Pressure to keep the price low
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Over The Counter Drugs Market, by Product
6.1. Introduction
6.2. Analgesics
6.3. Cough, Cold, & Flu Products
6.4. Dermatology Products
6.5. Gastrointestinal Products
6.6. Ophthalmic Products
6.7. Sleeping Aids
6.8. Vitamins, Mineral, & Supplements
6.9. Weight-Loss & Dietary Products

7. Over The Counter Drugs Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Stores
7.4. Retail Pharmacies

8. Americas Over The Counter Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Over The Counter Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Over The Counter Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Alembic Pharmaceuticals Ltd.
12.2. Alkem Laboratories Limited
12.3. Cipla, Inc.
12.4. Dr. Reddy's Laboratories
12.5. Glaxosmithkline PLC
12.6. Glenmark Pharmaceuticals Limited
12.7. Hetero Drugs Ltd.
12.8. Johnson & Johnson Pvt. Ltd.
12.9. Lupin Limited
12.10. Mankind Pharma
12.11. Mylan Pharmaceuticals Pvt. Ltd. by Viatris
12.12. Pfizer Inc.
12.13. Sanofi S.A.
12.14. Sun Pharmaceutical Industries Ltd.
12.15. Teva Pharmaceutical Industries Ltd.

13. Appendix
13.1. Discussion Guide
13.2. License & PricingList of Figures
FIGURE 1. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL OVER THE COUNTER DRUGS MARKET DYNAMICS
FIGURE 11. GLOBAL OVER THE COUNTER DRUGS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, & FLU PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 20. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, 2018-2030 (USD BILLION)
FIGURE 21. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, & SUPPLEMENTS , 2018-2030 (USD BILLION)
FIGURE 22. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS & DIETARY PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
FIGURE 24. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 25. GLOBAL OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2030
FIGURE 26. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 27. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD BILLION)
FIGURE 28. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 29. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 30. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 31. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 32. AMERICAS OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 33. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 34. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 35. CANADA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 36. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 37. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 38. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 39. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 40. UNITED STATES OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 41. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 42. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 43. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 44. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 45. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 46. CHINA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 47. INDIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 48. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 49. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 50. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 51. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. SINGAPORE OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 54. TAIWAN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 55. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 56. VIETNAM OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 57. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 59. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 61. DENMARK OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. EGYPT OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. FINLAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. ISRAEL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. ITALY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. NIGERIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. NORWAY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. POLAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. QATAR OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. SWEDEN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. SWITZERLAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. TURKEY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 80. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 81. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 82. GLOBAL OVER THE COUNTER DRUGS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 83. GLOBAL OVER THE COUNTER DRUGS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 84. GLOBAL OVER THE COUNTER DRUGS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. GLOBAL OVER THE COUNTER DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, & FLU PRODUCTS, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, & FLU PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, & FLU PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, & SUPPLEMENTS , 2018-2030 (USD BILLION)
TABLE 26. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, & SUPPLEMENTS , BY REGION, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, & SUPPLEMENTS , BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS & DIETARY PRODUCTS, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS & DIETARY PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS & DIETARY PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 35. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD BILLION)
TABLE 36. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD BILLION)
TABLE 37. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD BILLION)
TABLE 38. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD BILLION)
TABLE 39. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 40. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 41. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 42. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 43. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 44. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 45. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 46. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 47. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 48. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 49. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 50. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 51. CANADA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 52. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 53. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 54. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 55. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 56. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 57. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 58. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 59. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 60. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 61. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 62. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 63. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 64. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 65. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 66. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 67. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 68. CHINA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 69. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 70. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 71. INDIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 72. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 73. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 74. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 75. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 76. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 77. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 78. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 79. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 80. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 81. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 82. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 83. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 84. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 85. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 86. SINGAPORE OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 87. SINGAPORE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 88. SINGAPORE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 89. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 90. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 91. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 92. TAIWAN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 93. TAIWAN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 94. TAIWAN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 95. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 96. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 97. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 98. VIETNAM OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 99. VIETNAM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 100. VIETNAM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 105. DENMARK OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 106. DENMARK OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 107. DENMARK OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 108. EGYPT OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 109. EGYPT OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 110. EGYPT OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 111. FINLAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 112. FINLAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 113. FINLAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 114. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 115. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 116. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 117. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 119. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 120. ISRAEL OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 121. ISRAEL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 122. ISRAEL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 123. ITALY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 124. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 125. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 126. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 128. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 129. NIGERIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 130. NIGERIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 131. NIGERIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 132. NORWAY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 133. NORWAY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 134. NORWAY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 135. POLAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 136. POLAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 137. POLAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 138. QATAR OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 140. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 141. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 142. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 143. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 144. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 145. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 146. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 147. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 149. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 150. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 152. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 153. SWEDEN OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 154. SWEDEN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 155. SWEDEN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 156. SWITZERLAND OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 157. SWITZERLAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 158. SWITZERLAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 159. TURKEY OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 160. TURKEY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 161. TURKEY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 162. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 163. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 164. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 165. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 166. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 167. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD BILLION)
TABLE 168. GLOBAL OVER THE COUNTER DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 169. GLOBAL OVER THE COUNTER DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 170. GLOBAL OVER THE COUNTER DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 171. GLOBAL OVER THE COUNTER DRUGS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 172. GLOBAL OVER THE COUNTER DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 173. GLOBAL OVER THE COUNTER DRUGS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 174. GLOBAL OVER THE COUNTER DRUGS MARKET MERGER & ACQUISITION
TABLE 175. GLOBAL OVER THE COUNTER DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 176. GLOBAL OVER THE COUNTER DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 177. GLOBAL OVER THE COUNTER DRUGS MARKET INVESTMENT & FUNDING
TABLE 178. GLOBAL OVER THE COUNTER DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 179. GLOBAL OVER THE COUNTER DRUGS MARKET: LICENSE & PRICING